Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Aug;96(2):1042–1052. doi: 10.1172/JCI118090

Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration.

S Kapadia 1, J Lee 1, G Torre-Amione 1, H H Birdsall 1, T S Ma 1, D L Mann 1
PMCID: PMC286384  PMID: 7635940

Abstract

TNF alpha mRNA and protein biosynthesis were examined in the adult feline heart after stimulation with endotoxin. When freshly isolated hearts were stimulated with endotoxin in vitro, de novo TNF alpha mRNA expression occurred within 30 min, and TNF alpha protein production was detected within 60-75 min; however, TNF alpha mRNA and protein production were not detected in diluent-treated hearts. Immunohistochemical studies localized TNF alpha to endothelial cells, smooth muscle cells, and cardiac myocytes in the endotoxin-treated hearts, whereas TNF alpha immunostaining was absent in the diluent-treated hearts. To determine whether the cardiac myocyte was a source for TNF alpha production, two studies were performed. First, in situ hybridization studies, using highly specific biotinylated probes, demonstrated TNF alpha mRNA in cardiac myocytes from endotoxin-stimulated hearts; in contrast, TNF alpha mRNA was not expressed in myocytes from diluent-treated hearts. Second, TNF alpha protein production was observed when cultured cardiac myocytes were stimulated with endotoxin, whereas TNF alpha protein production was not detected in the diluent-treated cells. The functional significance of the intramyocardial production of TNF alpha was determined by examining cell motion in isolated cardiac myocytes treated with superfusates from endotoxin- and diluent-stimulated hearts. These studies showed that cell motion was depressed in myocytes treated with superfusates from the endotoxin-treated hearts, but was normal with the superfusates from the diluent-treated hearts; moreover, the negative inotropic effects of the superfusates from the endotoxin-treated hearts could be abrogated completely by pretreatment with an anti-TNF alpha antibody. Finally, endotoxin stimulation was also shown to result in the intramyocardial production of TNF alpha mRNA and protein in vivo. Thus, this study shows for the first time that the adult mammalian myocardium synthesizes biologically active TNF alpha.

Full text

PDF
1042

Images in this article

1046Image
on p.1046
1047Image
on p.1047
1047Image
on p.1047
1047Image
on p.1047
1048Image
on p.1048
1049Image
on p.1049
1050Image
on p.1050

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bucana C. D., Radinsky R., Dong Z., Sanchez R., Brigati D. J., Fidler I. J. A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells. J Histochem Cytochem. 1993 Apr;41(4):499–506. doi: 10.1177/41.4.8095509. [DOI] [PubMed] [Google Scholar]
  2. Calandra T., Baumgartner J. D., Grau G. E., Wu M. M., Lambert P. H., Schellekens J., Verhoef J., Glauser M. P. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis. 1990 May;161(5):982–987. doi: 10.1093/infdis/161.5.982. [DOI] [PubMed] [Google Scholar]
  3. Caput D., Beutler B., Hartog K., Thayer R., Brown-Shimer S., Cerami A. Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1670–1674. doi: 10.1073/pnas.83.6.1670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Casey L. C., Balk R. A., Bone R. C. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993 Oct 15;119(8):771–778. doi: 10.7326/0003-4819-119-8-199310150-00001. [DOI] [PubMed] [Google Scholar]
  5. Cooper G., 4th, Kent R. L., Mann D. L. Load induction of cardiac hypertrophy. J Mol Cell Cardiol. 1989 Dec;21 (Suppl 5):11–30. doi: 10.1016/0022-2828(89)90768-2. [DOI] [PubMed] [Google Scholar]
  6. Finkel M. S., Oddis C. V., Jacob T. D., Watkins S. C., Hattler B. G., Simmons R. L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992 Jul 17;257(5068):387–389. doi: 10.1126/science.1631560. [DOI] [PubMed] [Google Scholar]
  7. Friedman G., Gallily R., Chajek-Shaul T., Stein O., Shiloni E., Etienne J., Stein Y. Lipoprotein lipase in heart cell cultures is suppressed by bacterial lipopolysaccharide: an effect mediated by production of tumor necrosis factor. Biochim Biophys Acta. 1988 May 22;960(2):220–228. doi: 10.1016/0005-2760(88)90067-7. [DOI] [PubMed] [Google Scholar]
  8. Giroir B. P., Horton J. W., White D. J., McIntyre K. L., Lin C. Q. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol. 1994 Jul;267(1 Pt 2):H118–H124. doi: 10.1152/ajpheart.1994.267.1.H118. [DOI] [PubMed] [Google Scholar]
  9. Giroir B. P., Johnson J. H., Brown T., Allen G. L., Beutler B. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest. 1992 Sep;90(3):693–698. doi: 10.1172/JCI115939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gulick T., Chung M. K., Pieper S. J., Lange L. G., Schreiner G. F. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6753–6757. doi: 10.1073/pnas.86.17.6753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hesse D. G., Tracey K. J., Fong Y., Manogue K. R., Palladino M. A., Jr, Cerami A., Shires G. T., Lowry S. F. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet. 1988 Feb;166(2):147–153. [PubMed] [Google Scholar]
  12. Huang E. H., Morgan C. J., Sedmak D. D., Ferguson R. M., Orosz C. G. Alloantigenicity of human endothelial cells. IV. Derivation, characterization, and utilization of gonadal vein endothelia to control endothelial alloantigenicity during lymphocyte-endothelial interactions. Transplantation. 1994 Mar 15;57(5):703–711. [PubMed] [Google Scholar]
  13. Hung J., Lew W. Y. Cellular mechanisms of endotoxin-induced myocardial depression in rabbits. Circ Res. 1993 Jul;73(1):125–134. doi: 10.1161/01.res.73.1.125. [DOI] [PubMed] [Google Scholar]
  14. Hunt J. S., Chen H. L., Hu X. L., Chen T. Y., Morrison D. C. Tumor necrosis factor-alpha gene expression in the tissues of normal mice. Cytokine. 1992 Sep;4(5):340–346. doi: 10.1016/1043-4666(92)90076-4. [DOI] [PubMed] [Google Scholar]
  15. Iezzoni J. C., Kang J. H., Bucana C. D., Reed J. A., Brigati D. J. Rapid colorimetric detection of epidermal growth factor receptor mRNA by in situ hybridization. J Clin Lab Anal. 1993;7(5):247–251. doi: 10.1002/jcla.1860070502. [DOI] [PubMed] [Google Scholar]
  16. Kapadia S., Torre-Amione G., Yokoyama T., Mann D. L. Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro. Am J Physiol. 1995 Feb;268(2 Pt 2):H517–H525. doi: 10.1152/ajpheart.1995.268.2.H517. [DOI] [PubMed] [Google Scholar]
  17. Kita T., Tanaka N., Nagano T. The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat kidney after treatment with lipopolysaccharide. Int J Exp Pathol. 1993 Oct;74(5):471–479. [PMC free article] [PubMed] [Google Scholar]
  18. Kriegler M., Perez C., DeFay K., Albert I., Lu S. D. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell. 1988 Apr 8;53(1):45–53. doi: 10.1016/0092-8674(88)90486-2. [DOI] [PubMed] [Google Scholar]
  19. Lange L. G., Schreiner G. F. Immune mechanisms of cardiac disease. N Engl J Med. 1994 Apr 21;330(16):1129–1135. doi: 10.1056/NEJM199404213301607. [DOI] [PubMed] [Google Scholar]
  20. Lefer A. M. Role of a myocardial depressant factor in the pathogenesis of circulatory shock. Fed Proc. 1970 Nov-Dec;29(6):1836–1847. [PubMed] [Google Scholar]
  21. Ma T. S., Brink P. A., Perryman B., Roberts R. Improved quantification with validation of multiple mRNA species by polymerase chain reaction: application to human myocardial creatine kinase M and B. Cardiovasc Res. 1994 Apr;28(4):464–471. doi: 10.1093/cvr/28.4.464. [DOI] [PubMed] [Google Scholar]
  22. Mann D. L., Kent R. L., Cooper G., 4th Load regulation of the properties of adult feline cardiocytes: growth induction by cellular deformation. Circ Res. 1989 Jun;64(6):1079–1090. doi: 10.1161/01.res.64.6.1079. [DOI] [PubMed] [Google Scholar]
  23. Mann D. L., Kent R. L., Parsons B., Cooper G., 4th Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992 Feb;85(2):790–804. doi: 10.1161/01.cir.85.2.790. [DOI] [PubMed] [Google Scholar]
  24. Mann D. L., Urabe Y., Kent R. L., Vinciguerra S., Cooper G., 4th Cellular versus myocardial basis for the contractile dysfunction of hypertrophied myocardium. Circ Res. 1991 Feb;68(2):402–415. doi: 10.1161/01.res.68.2.402. [DOI] [PubMed] [Google Scholar]
  25. Michie H. R., Manogue K. R., Spriggs D. R., Revhaug A., O'Dwyer S., Dinarello C. A., Cerami A., Wolff S. M., Wilmore D. W. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988 Jun 9;318(23):1481–1486. doi: 10.1056/NEJM198806093182301. [DOI] [PubMed] [Google Scholar]
  26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  27. Nagano T., Kita T., Tanaka N. The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat liver after treatment with lipopolysaccharide. Int J Exp Pathol. 1992 Oct;73(5):675–683. [PMC free article] [PubMed] [Google Scholar]
  28. Nakata T., Suzuki K., Fujii J., Ishikawa M., Taniguchi N. Induction and release of manganese superoxide dismutase from mitochondria of human umbilical vein endothelial cells by tumor necrosis factor-alpha and interleukin-1 alpha. Int J Cancer. 1993 Oct 21;55(4):646–650. doi: 10.1002/ijc.2910550422. [DOI] [PubMed] [Google Scholar]
  29. Natanson C., Eichenholz P. W., Danner R. L., Eichacker P. Q., Hoffman W. D., Kuo G. C., Banks S. M., MacVittie T. J., Parrillo J. E. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med. 1989 Mar 1;169(3):823–832. doi: 10.1084/jem.169.3.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Parker M. M., Shelhamer J. H., Bacharach S. L., Green M. V., Natanson C., Frederick T. M., Damske B. A., Parrillo J. E. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984 Apr;100(4):483–490. doi: 10.7326/0003-4819-100-4-483. [DOI] [PubMed] [Google Scholar]
  31. Parrillo J. E., Burch C., Shelhamer J. H., Parker M. M., Natanson C., Schuette W. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest. 1985 Oct;76(4):1539–1553. doi: 10.1172/JCI112135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Parrillo J. E. Pathogenetic mechanisms of septic shock. N Engl J Med. 1993 May 20;328(20):1471–1477. doi: 10.1056/NEJM199305203282008. [DOI] [PubMed] [Google Scholar]
  33. Pizarro T. T., Malinowska K., Kovacs E. J., Clancy J., Jr, Robinson J. A., Piccinini L. A. Induction of TNF alpha and TNF beta gene expression in rat cardiac transplants during allograft rejection. Transplantation. 1993 Aug;56(2):399–404. doi: 10.1097/00007890-199308000-00029. [DOI] [PubMed] [Google Scholar]
  34. Schulz R., Nava E., Moncada S. Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 1992 Mar;105(3):575–580. doi: 10.1111/j.1476-5381.1992.tb09021.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Schumann R. R., Leong S. R., Flaggs G. W., Gray P. W., Wright S. D., Mathison J. C., Tobias P. S., Ulevitch R. J. Structure and function of lipopolysaccharide binding protein. Science. 1990 Sep 21;249(4975):1429–1431. doi: 10.1126/science.2402637. [DOI] [PubMed] [Google Scholar]
  36. Shaw G., Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 1986 Aug 29;46(5):659–667. doi: 10.1016/0092-8674(86)90341-7. [DOI] [PubMed] [Google Scholar]
  37. Suffredini A. F., Fromm R. E., Parker M. M., Brenner M., Kovacs J. A., Wesley R. A., Parrillo J. E. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989 Aug 3;321(5):280–287. doi: 10.1056/NEJM198908033210503. [DOI] [PubMed] [Google Scholar]
  38. Tanaka N., Kita T., Kasai K., Nagano T. The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat heart and lung during endotoxin shock. Virchows Arch. 1994;424(3):273–277. doi: 10.1007/BF00194611. [DOI] [PubMed] [Google Scholar]
  39. Tovey M. G., Content J., Gresser I., Gugenheim J., Blanchard B., Guymarho J., Poupart P., Gigou M., Shaw A., Fiers W. Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals. J Immunol. 1988 Nov 1;141(9):3106–3110. [PubMed] [Google Scholar]
  40. Tovey M. G. Expression of the genes of interferons and other cytokines in normal and diseased tissues of man. Experientia. 1989 Jun 15;45(6):526–535. doi: 10.1007/BF01990502. [DOI] [PubMed] [Google Scholar]
  41. Tracey K. J., Beutler B., Lowry S. F., Merryweather J., Wolpe S., Milsark I. W., Hariri R. J., Fahey T. J., 3rd, Zentella A., Albert J. D. Shock and tissue injury induced by recombinant human cachectin. Science. 1986 Oct 24;234(4775):470–474. doi: 10.1126/science.3764421. [DOI] [PubMed] [Google Scholar]
  42. Tracey K. J., Fong Y., Hesse D. G., Manogue K. R., Lee A. T., Kuo G. C., Lowry S. F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987 Dec 17;330(6149):662–664. doi: 10.1038/330662a0. [DOI] [PubMed] [Google Scholar]
  43. Tsujimoto M., Yokota S., Vilcek J., Weissmann G. Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Commun. 1986 Jun 30;137(3):1094–1100. doi: 10.1016/0006-291x(86)90337-2. [DOI] [PubMed] [Google Scholar]
  44. Ulich T. R., Guo K. Z., Irwin B., Remick D. G., Davatelis G. N. Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression. Am J Pathol. 1990 Nov;137(5):1173–1185. [PMC free article] [PubMed] [Google Scholar]
  45. Ulich T. R., Guo K., del Castillo J. Endotoxin-induced cytokine gene expression in vivo. I. Expression of tumor necrosis factor mRNA in visceral organs under physiologic conditions and during endotoxemia. Am J Pathol. 1989 Jan;134(1):11–14. [PMC free article] [PubMed] [Google Scholar]
  46. Vilcek J., Lee T. H. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem. 1991 Apr 25;266(12):7313–7316. [PubMed] [Google Scholar]
  47. Yokoyama T., Vaca L., Rossen R. D., Durante W., Hazarika P., Mann D. L. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest. 1993 Nov;92(5):2303–2312. doi: 10.1172/JCI116834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Youker K., Smith C. W., Anderson D. C., Miller D., Michael L. H., Rossen R. D., Entman M. L. Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest. 1992 Feb;89(2):602–609. doi: 10.1172/JCI115626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. de Groote M. A., Martin M. A., Densen P., Pfaller M. A., Wenzel R. P. Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo. JAMA. 1989 Jul 14;262(2):249–251. doi: 10.1001/jama.262.2.249. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES